Biota Provides Update on BARDA Contract for Laninamivir Octanoate

Biota Provides Update on BARDA Contract for Laninamivir Octanoate

[GlobeNewswire] – ATLANTA — Biota Pharmaceuticals, Inc. (the Company) today announced that last night it received notice from the Department of Health and Human Services Office of Assistant Secretary for Preparedness … more

View todays social media effects on BOTA

View the latest stocks trending across Twitter. Click to view dashboard

See who Biota is hiring next, click here to view

Share this post